Active implantable medical devices are increasingly used for the treatment of pathologies with, in 2025, an estimated market of $ 30 billion. The emergence of new generations of AIMD requires miniaturization, communication and energy efficiency solutions. Tech2AIM thus aims to develop a BtoB sector of breakthrough technological components with high added value around the transfer of energy by ultrasound and the functionalization of titanium (radiofrequency communication and ECG electrodes).
There are no benefits for this project at this time
Strategic business lines
Matériaux et composants pour l'électronique
Referent of the project
07 86 53 38 70
Centre val de loire